HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annette Scheid Selected Research

Hypoxia (Hypoxemia)

12/2014The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.
7/2004Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis.
4/2003The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
3/2002Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annette Scheid Research Topics

Disease

4Hypoxia (Hypoxemia)
12/2014 - 03/2002
1Pulmonary Hypertension
12/2014
1Systemic Scleroderma (Systemic Sclerosis)
07/2004
1Sarcoma (Soft Tissue Sarcoma)
11/2002

Drug/Important Bio-Agent (IBA)

3Oxygen (Dioxygen)IBA
07/2004 - 11/2002
1Semaxinib (SU5416)IBA
12/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2004
1Transforming Growth Factor beta3 (TGF beta 3)IBA
03/2002
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2002

Therapy/Procedure

1Injections
12/2014
1Electrodes (Electrode)
11/2002